Clinical Trial Update: Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating Lucentis (ranibizumab) for diabetic retinopathy; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Moorfields Eye Hospital NHS Foundation Trust | Conditions: Diabetic Retinopathy | Phase 4 | Status: COMPLETED